Capital Investment Counsel Inc’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$511K Hold
6,000
0.06% 125
2025
Q4
$474K Hold
6,000
0.06% 126
2025
Q3
$480K Hold
6,000
0.06% 125
2025
Q2
$545K Hold
6,000
0.07% 116
2025
Q1
$562K Hold
6,000
0.08% 109
2024
Q4
$545K Hold
6,000
0.08% 107
2024
Q3
$623K Hold
6,000
0.09% 105
2024
Q2
$582K Hold
6,000
0.09% 105
2024
Q1
$540K Sell
6,000
-700
-10% -$59.3K 0.09% 104
2023
Q4
$534K Hold
6,700
0.09% 104
2023
Q3
$476K Hold
6,700
0.1% 106
2023
Q2
$516K Hold
6,700
0.1% 104
2023
Q1
$504K Hold
6,700
0.11% 102
2022
Q4
$528K Hold
6,700
0.12% 101
2022
Q3
$471K Hold
6,700
0.14% 97
2022
Q2
$537K Hold
6,700
0.13% 99
2022
Q1
$508K Buy
+6,700
New +$531K 0.11% 114

Other funds holding CL

Capital Investment Counsel Inc's CL Position: Q1 2026 in Review

Capital Investment Counsel Inc held its Colgate-Palmolive (CL) position steady in Q1 2026 at 6,000 shares worth $511K. The position accounts for 0.06% of the portfolio, ranked #125.

Capital Investment Counsel Inc first reported a position in CL in Q1 2022 and has held it in 17 quarters since. The position peaked at $623K in Q3 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Capital Investment Counsel Inc held 6,000 shares of Colgate-Palmolive worth $511K as of Q1 2026.
  • Capital Investment Counsel Inc left its Colgate-Palmolive share count unchanged in Q1 2026.
  • Colgate-Palmolive made up 0.06% of Capital Investment Counsel Inc's portfolio in Q1 2026, its #125 holding.
  • Capital Investment Counsel Inc first reported a position in Colgate-Palmolive in Q1 2022 and has held it in 17 quarters since.
  • Capital Investment Counsel Inc's Colgate-Palmolive position peaked at $623K in Q3 2024.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Capital Investment Counsel Inc's 13F filing for Q1 2026, filed 21 Apr 2026.